Company Nextage Therapeutics Ltd TEL AVIV STOCK EXCHANGE
Equities
NXTG
IL0004330119
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Abraham Dreazen
CEO | Chief Executive Officer | 40 | 11/08/20 |
Ishai Gandelsman
DFI | Director of Finance/CFO | 61 | 09/07/22 |
General Counsel | 53 | 11/08/20 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 31/12/93 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yaacov Elinav
BRD | Director/Board Member | 79 | 11/08/20 |
Israel Makov
CHM | Chairman | 85 | 20/11/11 |
Ron Grupel
BRD | Director/Board Member | 73 | 12/10/14 |
Jakob Ripshtein
BRD | Director/Board Member | 57 | 11/08/20 |
Orna Dreazen
BRD | Director/Board Member | 69 | 11/08/20 |
Director/Board Member | 59 | 11/08/20 | |
Director/Board Member | 72 | 11/08/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,601,972 | 5,226,508 ( 16.03 %) | 0 | 16.03 % |
Company contact information
NEXTAGE Therapeutics Ltd.
Einstein Street, Building 13B Weizmann Science Park
7403617, Ness Ziona
+
http://www.nxtg.co.ilSector
1st Jan change | Capi. | |
---|---|---|
-29.78% | 9.59B | |
-2.96% | 3.21B | |
+28.23% | 2.92B | |
-14.73% | 2.15B | |
-15.05% | 1.79B | |
+69.62% | 1.47B | |
+23.08% | 770M | |
-2.84% | 761M | |
-24.08% | 548M |